Fibroblast growth factor for use in the prevention and treatment of viral infections
CA 2047203 A1 · Owner: Mazue, Guy · Inventors: Mazue, Guy; Battistini, Carlo; Carminati, Paolo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
57) Abstract, This invention refers to fibroblast growth factors useful in the prevention and treatment of viral infections caused by enveloped viruses such as, for example, type 2 herpes simplex virus (HSV2) human respiratory syncytial virus (HRSV) Semliki, Forest virus (SFV), the virus responsible for the acquired immuno deficiency syndrome (HIV) and the virus responsible for the Moloney Sarcoma (MSV).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 18, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 18, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 18, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.